Report Detail

Request for Sample of this report

Chemical & Material Global Azilsartan Kamedoxomil API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4703962
    • |
  • 01 June, 2026
    • |
  • Global
    • |
  • 88 Pages
    • |
  • GIR
    • |
  • Chemical & Material

According to our (Global Info Research) latest study, the global Azilsartan Kamedoxomil API market size was valued at US$ 186 million in 2025 and is forecast to a readjusted size of US$ 269 million by 2032 with a CAGR of 5.4% during review period.
Azilsartan Kamedoxomil API is a prodrug of a new generation of angiotensin II receptor antagonists (ARB class) used for the treatment of hypertension. Its structural feature is that it can improve oral absorption rate and be converted into the active ingredient valsartan in the body, thereby exerting a stronger antihypertensive effect. This active pharmaceutical ingredient belongs to the high-end cardiovascular API of multi-step organic synthesis, with complex production processes and high requirements for impurity control, crystal stability, and registration standards. It usually meets international pharmacopoeia standards such as USP/EP. In 2025, global Azilsartan Kamedoxomil API production reached approximately 123 MT, with an average global market price of around US$ 1,468 per kg.The annual production capacity of azilsartan kamedoxomil API is 180 tons, with a gross profit margin of about 30%.
Upstream raw materials: indazole/imidazole heterocyclic intermediates; Medoxomil esterification reagent (key structural source); Potassium salt reagents (KOH, etc.); Organic solvents (DMF, acetonitrile, methanol); Catalysts and protective reagents.
Downstream: Mesartan potassium tablets (anti hypertensive).
Raw material costs account for 45% -60%; Manufacturing cost accounts for 15% -25%; Quality control and compliance costs account for 8% -15%; Environmental protection and safety costs account for 5% -10%; R&D and process optimization account for 5% -10%.
The active pharmaceutical ingredient of azilsartan kamedoxomil API belongs to the growth segment of high-end ARB generic drugs. Its market demand is driven by the stable growth of the global hypertension patient base, while benefiting from the trend of ARB drugs upgrading from older generation products such as losartan and valsartan to the new generation of highly effective drugs. The current market is still in the transitional stage of "original research and development oriented imitation and mass production", and Chinese and Indian companies are gradually entering the commercial supply system. However, the overall competitive landscape has not been fully saturated, so the price and profit levels are higher than traditional sartan APIs. The core competitive points of the industry lie in registration access (DMF/ANDA), optimization of synthesis processes, and the ability to control large-scale costs. In the long run, it has stable demand and moderate growth potential, and belongs to the "high-end upgraded raw material drug market in mature therapeutic fields".
This report is a detailed and comprehensive analysis for global Azilsartan Kamedoxomil API market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Azilsartan Kamedoxomil API market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Azilsartan Kamedoxomil API market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Azilsartan Kamedoxomil API market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/kg), 2021-2032
Global Azilsartan Kamedoxomil API market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/kg), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Azilsartan Kamedoxomil API
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Azilsartan Kamedoxomil API market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Takeda Pharmaceuticals, LGM Pharma, Zhuhai Rundu Pharmaceutical, Hefei Lifeon Pharmaceutical, Guangzhou Standard Pharma, Jiangxi Synergy Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Azilsartan Kamedoxomil API market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Purity<99%
Purity≥99%
Market segment by Customer
Formulators
CDMO/CMO
Market segment by Application
40mg Mesartan Potassium Tablets
80mg Mesartan Potassium Tablets
Major players covered
Takeda Pharmaceuticals
LGM Pharma
Zhuhai Rundu Pharmaceutical
Hefei Lifeon Pharmaceutical
Guangzhou Standard Pharma
Jiangxi Synergy Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Azilsartan Kamedoxomil API product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Azilsartan Kamedoxomil API, with price, sales quantity, revenue, and global market share of Azilsartan Kamedoxomil API from 2021 to 2026.
Chapter 3, the Azilsartan Kamedoxomil API competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Azilsartan Kamedoxomil API breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Azilsartan Kamedoxomil API market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Azilsartan Kamedoxomil API.
Chapter 14 and 15, to describe Azilsartan Kamedoxomil API sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Azilsartan Kamedoxomil API Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Purity<99%
    • 1.3.3 Purity≥99%
  • 1.4 Market Analysis by Customer
    • 1.4.1 Overview: Global Azilsartan Kamedoxomil API Consumption Value by Customer: 2021 Versus 2025 Versus 2032
    • 1.4.2 Formulators
    • 1.4.3 CDMO/CMO
  • 1.5 Market Analysis by Application
    • 1.5.1 Overview: Global Azilsartan Kamedoxomil API Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.5.2 40mg Mesartan Potassium Tablets
    • 1.5.3 80mg Mesartan Potassium Tablets
  • 1.6 Global Azilsartan Kamedoxomil API Market Size & Forecast
    • 1.6.1 Global Azilsartan Kamedoxomil API Consumption Value (2021 & 2025 & 2032)
    • 1.6.2 Global Azilsartan Kamedoxomil API Sales Quantity (2021-2032)
    • 1.6.3 Global Azilsartan Kamedoxomil API Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Takeda Pharmaceuticals
    • 2.1.1 Takeda Pharmaceuticals Details
    • 2.1.2 Takeda Pharmaceuticals Major Business
    • 2.1.3 Takeda Pharmaceuticals Azilsartan Kamedoxomil API Product and Services
    • 2.1.4 Takeda Pharmaceuticals Azilsartan Kamedoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Takeda Pharmaceuticals Recent Developments/Updates
  • 2.2 LGM Pharma
    • 2.2.1 LGM Pharma Details
    • 2.2.2 LGM Pharma Major Business
    • 2.2.3 LGM Pharma Azilsartan Kamedoxomil API Product and Services
    • 2.2.4 LGM Pharma Azilsartan Kamedoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 LGM Pharma Recent Developments/Updates
  • 2.3 Zhuhai Rundu Pharmaceutical
    • 2.3.1 Zhuhai Rundu Pharmaceutical Details
    • 2.3.2 Zhuhai Rundu Pharmaceutical Major Business
    • 2.3.3 Zhuhai Rundu Pharmaceutical Azilsartan Kamedoxomil API Product and Services
    • 2.3.4 Zhuhai Rundu Pharmaceutical Azilsartan Kamedoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Zhuhai Rundu Pharmaceutical Recent Developments/Updates
  • 2.4 Hefei Lifeon Pharmaceutical
    • 2.4.1 Hefei Lifeon Pharmaceutical Details
    • 2.4.2 Hefei Lifeon Pharmaceutical Major Business
    • 2.4.3 Hefei Lifeon Pharmaceutical Azilsartan Kamedoxomil API Product and Services
    • 2.4.4 Hefei Lifeon Pharmaceutical Azilsartan Kamedoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Hefei Lifeon Pharmaceutical Recent Developments/Updates
  • 2.5 Guangzhou Standard Pharma
    • 2.5.1 Guangzhou Standard Pharma Details
    • 2.5.2 Guangzhou Standard Pharma Major Business
    • 2.5.3 Guangzhou Standard Pharma Azilsartan Kamedoxomil API Product and Services
    • 2.5.4 Guangzhou Standard Pharma Azilsartan Kamedoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Guangzhou Standard Pharma Recent Developments/Updates
  • 2.6 Jiangxi Synergy Pharmaceutical
    • 2.6.1 Jiangxi Synergy Pharmaceutical Details
    • 2.6.2 Jiangxi Synergy Pharmaceutical Major Business
    • 2.6.3 Jiangxi Synergy Pharmaceutical Azilsartan Kamedoxomil API Product and Services
    • 2.6.4 Jiangxi Synergy Pharmaceutical Azilsartan Kamedoxomil API Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Jiangxi Synergy Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Azilsartan Kamedoxomil API by Manufacturer

  • 3.1 Global Azilsartan Kamedoxomil API Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Azilsartan Kamedoxomil API Revenue by Manufacturer (2021-2026)
  • 3.3 Global Azilsartan Kamedoxomil API Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Azilsartan Kamedoxomil API by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Azilsartan Kamedoxomil API Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Azilsartan Kamedoxomil API Manufacturer Market Share in 2025
  • 3.5 Azilsartan Kamedoxomil API Market: Overall Company Footprint Analysis
    • 3.5.1 Azilsartan Kamedoxomil API Market: Region Footprint
    • 3.5.2 Azilsartan Kamedoxomil API Market: Company Product Type Footprint
    • 3.5.3 Azilsartan Kamedoxomil API Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Azilsartan Kamedoxomil API Market Size by Region
    • 4.1.1 Global Azilsartan Kamedoxomil API Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Azilsartan Kamedoxomil API Consumption Value by Region (2021-2032)
    • 4.1.3 Global Azilsartan Kamedoxomil API Average Price by Region (2021-2032)
  • 4.2 North America Azilsartan Kamedoxomil API Consumption Value (2021-2032)
  • 4.3 Europe Azilsartan Kamedoxomil API Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Azilsartan Kamedoxomil API Consumption Value (2021-2032)
  • 4.5 South America Azilsartan Kamedoxomil API Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Azilsartan Kamedoxomil API Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Azilsartan Kamedoxomil API Sales Quantity by Type (2021-2032)
  • 5.2 Global Azilsartan Kamedoxomil API Consumption Value by Type (2021-2032)
  • 5.3 Global Azilsartan Kamedoxomil API Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Azilsartan Kamedoxomil API Sales Quantity by Application (2021-2032)
  • 6.2 Global Azilsartan Kamedoxomil API Consumption Value by Application (2021-2032)
  • 6.3 Global Azilsartan Kamedoxomil API Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Azilsartan Kamedoxomil API Sales Quantity by Type (2021-2032)
  • 7.2 North America Azilsartan Kamedoxomil API Sales Quantity by Application (2021-2032)
  • 7.3 North America Azilsartan Kamedoxomil API Market Size by Country
    • 7.3.1 North America Azilsartan Kamedoxomil API Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Azilsartan Kamedoxomil API Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Azilsartan Kamedoxomil API Sales Quantity by Type (2021-2032)
  • 8.2 Europe Azilsartan Kamedoxomil API Sales Quantity by Application (2021-2032)
  • 8.3 Europe Azilsartan Kamedoxomil API Market Size by Country
    • 8.3.1 Europe Azilsartan Kamedoxomil API Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Azilsartan Kamedoxomil API Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Azilsartan Kamedoxomil API Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Azilsartan Kamedoxomil API Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Azilsartan Kamedoxomil API Market Size by Region
    • 9.3.1 Asia-Pacific Azilsartan Kamedoxomil API Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Azilsartan Kamedoxomil API Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Azilsartan Kamedoxomil API Sales Quantity by Type (2021-2032)
  • 10.2 South America Azilsartan Kamedoxomil API Sales Quantity by Application (2021-2032)
  • 10.3 South America Azilsartan Kamedoxomil API Market Size by Country
    • 10.3.1 South America Azilsartan Kamedoxomil API Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Azilsartan Kamedoxomil API Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Azilsartan Kamedoxomil API Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Azilsartan Kamedoxomil API Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Azilsartan Kamedoxomil API Market Size by Country
    • 11.3.1 Middle East & Africa Azilsartan Kamedoxomil API Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Azilsartan Kamedoxomil API Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Azilsartan Kamedoxomil API Market Drivers
  • 12.2 Azilsartan Kamedoxomil API Market Restraints
  • 12.3 Azilsartan Kamedoxomil API Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Azilsartan Kamedoxomil API and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Azilsartan Kamedoxomil API
  • 13.3 Azilsartan Kamedoxomil API Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Azilsartan Kamedoxomil API Typical Distributors
  • 14.3 Azilsartan Kamedoxomil API Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Azilsartan Kamedoxomil API. Industry analysis & Market Report on Azilsartan Kamedoxomil API is a syndicated market report, published as Global Azilsartan Kamedoxomil API Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Azilsartan Kamedoxomil API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo